| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |